The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907.
 
Hyman B. Muss
Consulting or Advisory Role - Eisai; pfizer
Research Funding - numerous at UNC (Inst)
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Constance T. Cirrincione
No Relationships to Disclose
 
Maria Theodoulou
Speakers' Bureau - Genentech; Novartis
 
Arti Hurria
Consulting or Advisory Role - Boehringer Ingelheim; GTx; Seagen
Research Funding - Celgene (Inst); GlaxoSmithKline (Inst)
 
Harvey Jay Cohen
No Relationships to Disclose
 
Ann Partridge
No Relationships to Disclose
 
Larry Norton
Employment - Celgene; Genentech; Innocrin Pharma
Stock and Other Ownership Interests - GenDx; Nile Pharma; OncoMed; Tigris
Honoraria - Celgene; Genentech
Consulting or Advisory Role - Celgene; Genentech; Innocrin Pharma
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Novartis